Prot #ARC-6: A Phase 1b/2, Open-Label, Randomized Platform Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Castrate Resistant Prostate Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date11/12/2011/12/23

Funding

  • Novella Clinical, LLC (Prot #ARC-6)
  • Arcus Biosciences, Inc (Prot #ARC-6)